• 11-01-2021

DeepIntent Survey Reveals That Pharmaceutical Advertising Motivates Patients to Research Treatment and Medication Options

DeepIntent surveyed 1,244 U.S. patients in August 2021 about their attitudes toward pharmaceutical ads and whether they find them relevant.

In this article, Pharmaceutical Executive Magazine shares key takeaways from the survey revealing how advertising motivates patients to research their treatment and medication options. DeepIntent’s CEO Chris Paquette also shares the opportunities healthcare marketers can act on as a result of this research.

Read more here.

More News

Article
Connected TV works ‘harder and smarter’ for the ad dollar, new analysis finds
2-6-2022
As more and more people flock to streaming channels over traditional TV, pharma ad dollars are following them. In this article for Fierce Pharma,...
Read More
Hands typing on laptop with a line graph on screen
Article
Tapping new tech helps marketers matchmake rare disease drugs for elusive patients
1-19-2022
Treating rare diseases is challenging enough, so you can imagine how difficult it is to reach the right healthcare audiences with info about specialty...
Read More
2022 image
Article
Pharma marketing 2022: More digital shifts for reps, ads and drug launches, plus reputation and the metaverse
1-4-2022
What trends can healthcare marketers expect in 2022? In this article for Endpoints News, CEO Chris Paquette discusses how pharma brands will be increasing...
Read More